[Maintaining independence. New protease inhibitor receives drug approval recommendation].

[Maintaining independence. New protease inhibitor receives drug approval recommendation]. [electronic resource] - MMW Fortschritte der Medizin Apr 2004 - 84-5 p. digital

Publication Type: News

1438-3276


Carbamates
Clinical Trials as Topic
Drug Administration Schedule
Drug Approval--legislation & jurisprudence
Drug Resistance, Multiple, Viral--drug effects
Drug Therapy, Combination
Europe
Furans
HIV Infections--drug therapy
HIV Protease Inhibitors--adverse effects
HIV-1--drug effects
Humans
Organophosphates--adverse effects
Sulfonamides--adverse effects
Viral Load